Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction

References

• Linden MD, Jackson DE. Platelets: pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol 2010;42:1762–1766. doi: 10.1016/j.biocel.2010.07.012.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012;64:676–705. doi: 10.1124/pr.112.005983.
   PubMed Web of Science ®Google Scholar
• Aatonen MT, Ohman T, Nyman TA, Laitinen S, Grönholm M, Siljander PR. Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 2014:3.
   Google Scholar
• Rank A, Nieuwland R, Delker R, Köhler A, Toth B, Pihusch V, Wilkowski R, Pihusch R. Cellular origin of platelet-derived microparticles in vivo. Thromb Res 2010;126:e255–e259. doi: 10.1016/j.thromres.2010.07.012.
   PubMed Web of Science ®Google Scholar
• Brisson AR, Tan S, Linares R, Gounou C, Arraud N. Extracellular vesicles from activated platelets: a semiquantitative cryo-electron microscopy and immuno-gold labeling study. Platelets 2017;28:263–271. doi: 10.1080/09537104.2016.1268255.
   PubMed Web of Science ®Google Scholar
• Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999;99:2577–2582.
   PubMed Web of Science ®Google Scholar
• Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003;197:158–1598. doi: 10.1084/jem.20021868.
   Web of Science ®Google Scholar
• Bevers EM, Williamson PL. Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol Rev 2016;96:605–645. doi: 10.1152/physrev.00020.2015.
   PubMed Web of Science ®Google Scholar
• Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012;34:43–62. doi: 10.1007/s00281-011-0290-8.
   PubMed Web of Science ®Google Scholar
• Ridger VC, Boulanger CM1, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat ML, Boilard E, Buzas EI, Caporali A, Dignat-George F, et al. Microvesicles in vascular homeostasis and diseases. Position paper of the European Society of Cardiology (ESC) working group on atherosclerosis and vascular biology. Thromb Haemost 2017;117:1296–1316. doi: 10.1160/TH16-12-0943.
   PubMed Web of Science ®Google Scholar
• Boulanger CM, Loyer X, Rautou PE, Amabile N. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol 2017;14:259–272. doi: 10.1038/nrcardio.2017.7.
   PubMed Web of Science ®Google Scholar
• Badimon L, Suades R, Fuentes E, Palomo I, Padró T. Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis. Front Pharmacol 2016;7:293. doi: 10.3389/fphar.2016.00323.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–1131. doi: 10.1056/NEJMoa1707914.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017;2018(39):119–177.
   Google Scholar
• Kubisa MJ, Jezewski MP, Gasecka A, Siller-Matula JM, Postuła M. Ticagrelor - toward more efficient platelet inhibition and beyond. Ther Clin Risk Manag 2018;14:129–140. doi: 10.2147/TCRM.S152369.
   PubMed Web of Science ®Google Scholar
• Kim S, Kunapuli SP. P2Y12 receptor in platelet activation. Platelets 2011;22:56–60. doi: 10.3109/09537104.2010.497231.
   PubMed Web of Science ®Google Scholar
• Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes. Basic Res Cardiol 2010;105:379–387. doi: 10.1007/s00395-009-0073-8.
   PubMed Web of Science ®Google Scholar
• Wang L, Jacobsen SE, Bengtsson A, Erlinge D. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 2004;5:16. doi: 10.1186/1471-2172-5-16.
   PubMedGoogle Scholar
• Simon J, Filippov AK, Göransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA, et al. Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 2002;277:31390–31400. doi: 10.1074/jbc.M110714200.
   PubMed Web of Science ®Google Scholar
• Shanker G, Kontos JL, Eckman DM, Wesley-Farrington D, Sane DC. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis 2006;22:213–220. doi: 10.1007/s11239-006-9033-4.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med 2009;361:1045–1057. doi: 10.1056/NEJMoa0904327.
   PubMed Web of Science ®Google Scholar
• Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, et al. PLATO Investigators. Platelet-related biomarkers and their response to inhibition with aspirin and P2Y12-receptor antagonists in patients with acute coronary syndrome. J Thromb Thrombolysis 2017;44:145–153. doi: 10.1007/s11239-017-1516-y.
   PubMed Web of Science ®Google Scholar
• Husted S, Storey RF, Harrington RA, Emanuelsson H, Cannon CP. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel. Clin Cardiol 2010;33:206–212. doi: 10.1002/clc.20732.
   PubMed Web of Science ®Google Scholar
• Kiers D, van der Heijden WA, van Ede L, Gerretsen J, de Mast Q, van der Ven AJ, El Messaoudi S, Rongen GA, Gomes M, Kox M, et al. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia. Thromb Haemost 2017;117:1798–1807. doi: 10.1160/TH16-10-0799.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, et al. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015;35: 2562–257. doi: 10.1161/ATVBAHA.115.306528.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Pulcinelli FM, Lenti L, Gazzaniga PP. Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis? Thromb Haemost 1999;81:472–473. doi: 10.1055/s-0037-1614504.
   PubMed Web of Science ®Google Scholar
• Halldórsdóttir AM, Stoker J, Porche-Sorbet R, Eby CS. Soluble CD40 ligand measurement inaccuracies attributable to specimentype, processing time, and ELISA method. Clin Chem 2005;51:1054–1057. doi: 10.1373/clinchem.2005.048199.
   PubMed Web of Science ®Google Scholar
• Gasecka A, Böing AN, Filipiak KJ, Nieuwland R. Platelet extracellular vesicles as biomarkers for arterial thrombosis. Platelets 2017;28:228–234. doi: 10.1080/09537104.2016.1254174.
   PubMed Web of Science ®Google Scholar
• Yuana Y, Böing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, Buhr E, Sturk A, Nieuwland R. Handling and storage of human body fluids for analysis of extracellular vesicles. J Extracell Vesicles 2015;4:29260. doi: 10.3402/jev.v4.29260.
   PubMed Web of Science ®Google Scholar
• Gasecka A, Nieuwland R, van der Pol E, Hajji N, Ćwiek A, Pluta K, Konwerski M, Filipiak KJ. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets: preliminary results. Cardiol J 2018; [ahead of print].
   PubMedGoogle Scholar
• Behan MW, Fox SC, Heptinstall S, Storey RF. Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes. Platelets 2005;16:73–80. doi: 10.1080/09537100400005634.
   PubMed Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, Emanueli C, Gasecka A, Hendrix A, Hill AF, et al. Methodological guidelines to study extracellular vesicles. Circ Res 2017;120:1632–1648. doi: 10.1161/CIRCRESAHA.117.309417.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Böing AN, Gool EL, Nieuwland R. Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost 2016;14:48–56. doi: 10.1111/jth.13190.
   PubMed Web of Science ®Google Scholar
• van der Zee PM, Biró E, Ko Y, de Winter RJ, Hack CE, Sturk A, Nieuwland R. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52(4):657–664. doi: 10.1373/clinchem.2005.057414.
   PubMed Web of Science ®Google Scholar
• Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012;43:31–35. doi: 10.1016/j.arcmed.2012.01.006.
   PubMed Web of Science ®Google Scholar
• Giannopoulos G, Oudatzis G, Paterakis G, Synetos A, Tampaki E, Bouras G, Hahalis G, Alexopoulos D, Tousoulis D, Cleman MW, et al. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty. Int J Cardiol 2014;176:145–150. doi: 10.1016/j.ijcard.2014.07.022.
   PubMed Web of Science ®Google Scholar
• van der Pol E, de Rond L, Coumans FAW, Gool EL, Böing AN, Sturk A, Nieuwland R, van Leeuwen TG. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. Nanomedicine 2018;14(3):801–810. doi: 10.1016/j.nano.2017.12.012.
   PubMed Web of Science ®Google Scholar
• Mackman N. The role of tissue factor and factor viia in hemostasis. Anesth Analg 2009;108(5):1447–1452. doi: 10.1213/ane.0b013e31819bceb1.
   PubMed Web of Science ®Google Scholar
• Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS One 2017;12(2):e0172558. doi: 10.1371/journal.pone.0172558.
   PubMed Web of Science ®Google Scholar
• Krüger JC, Meves SH, Kara K, Mügge A, Neubauer H. Monitoring ASA and P2Y12-specific platelet inhibition-comparison of conventional (single) and multiple electrode aggregometry. Scand J Clin Lab Invest 2014;74:568–574. doi: 10.3109/00365513.2014.913305.
   PubMed Web of Science ®Google Scholar
• Ray S. Clopidogrel resistance: the way forward. Indian Heart J 2014;66:530–534. doi: 10.1016/j.ihj.2014.08.012.
   PubMedGoogle Scholar
• Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Angelidis C, Petousis S, Stakos D, Parissis H, et al. In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome. Am Heart J 2014;167:68–76.e2. doi: 10.1016/j.ahj.2013.10.010.
   PubMed Web of Science ®Google Scholar
• Zettler ME, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY; TRANSLATE-ACS Investigators. Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study. Am Heart J 2017;183:62–68. doi: 10.1016/j.ahj.2016.10.006.
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; European Platelet Academy. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors - is an algorithm the answer? Thromb Haemost 2015;113:37–52. doi: 10.1160/TH14-03-0238.
   PubMed Web of Science ®Google Scholar